Assessment of Admission to the ICU of Onco-hematological Patients.

NCT ID: NCT06113601

Last Updated: 2023-11-02

Basic Information

• Recruitment Status: UNKNOWN
• Total Enrollment: 800 participants
• Study Classification: OBSERVATIONAL
• Study Start Date: 2024-01-01
• Study Completion Date: 2024-09-01

Brief Summary

Multicenter, observational and prospective study.

Detailed Description

The data collection period will include 6 consecutive months, starting from the date of acceptance or conformity of the CEIC. Or, until an adequate sample size is reached that guarantees the statistical relevance of said analysis. All patients will subsequently be followed up 3 months after discharge from the ICU.

Conditions

Hematological Diseases; Critical Illness

Study Design

• Observational Model Type: COHORT
• Study Time Perspective: PROSPECTIVE

Study Groups

Patients admitted to the ICU.

There is no intervention.

Intervention Type: OTHER

There is no intervention in the study.

Patients who are not admitted to the ICU.

There is no intervention.

Intervention Type: OTHER

There is no intervention in the study.

Interventions

There is no intervention.

There is no intervention in the study.

Intervention Type: OTHER

Eligibility Criteria

Inclusion Criteria

• Adults
• Solid organ tumor or hematological malignancy,

Exclusion Criteria

-under 18 years old

• Minimum Eligible Age: 18 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

University Hospital A Coruña

OTHER

Sponsor Role: lead

Responsible Party

Elena Cuenca Fito

Principal Investigator

Responsibility Role: PRINCIPAL_INVESTIGATOR

Central Contacts

Elena Cuenca Fito

Role: CONTACT

ecuencafito@gmail.com

647113703

Other Identifiers

23772377

Identifier Type: -

Identifier Source: org_study_id